Prescient Therapeutics LimitedASX: PTX

Encouraging data from PTX-200 ovarian cancer trial

Dec 12, 2019 at 4:22 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment